Edwards Lifesciences Corporation

EW
Passed

Company Overview

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Country
US
Market Cap
$44.97B
Last Fiscal Year
2023
Final Shariah Status
Passed
Compliance Analysis Overview

Shariah Compliance Benchmarks:

  • Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
  • Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
Business Compliance
0.73% passed
5% Threshold
0.7%
Liabilities Compliance
1.55% passed
33% Threshold
1.6%
Final Shariah Status
Passed

This stock meets all Shariah compliance criteria according to AAOIFI standards.

Stock Information
Name Edwards Lifesciences Corporation
Ticker EW
Main Business Medical Devices
Type Common Stock
Industry Medical Devices
Country US
Market Cap $44.97 B

Shariah Analysis Breakdown

Business compliance Breakdown
Revenue Segment Value ($M) Non-Compliant ($M) Reason
Transcatheter Aortic Valve Replacement $3,518.2 $0.0 -
Transcatheter Mitral and Tricuspid Therapies $116.1 $0.0 -
Surgical Heart Valve Therapy $893.1 $0.0 -
Critical Care $855.0 $0.0 -
Interest income $35.5 $35.5 -
Other income $2.6 $3.8 Gain on insurance settlement
Total $5,420.5 $39.3 0.73% (passed)
Liabilities Compliance Breakdown
Liability Item Value ($M) % of Market Cap
current debt and capital lease obligation $24,900,000.0 0.06%
long term debt and capital lease obligation $670,000,000.0 1.49%
Total Interest-Bearing Debt $694,900,000.0 1.55%
Market Capitalization $44,972,250,000.0 100.00%
Compliance Status Threshold: 33% passed